NASDAQ:CTXR

Citius Pharmaceuticals Stock Insider Trading

Healthcare > Biotechnology

Buy CTXR

*Your capital is at risk

$0.570

-0.0620 (-9.81%)

At Close: Jul 31, 2026

Citius Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -32.10. In total, the insiders bought 26.06M and sold 16.56M CTXR shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	-32.10
● Buy	26.06M shares
● Sell	16.56M shares
76% Buy Activity Weak Positive Correlation
Sell Signal Medium Confidence Jul 27, 2026 Analysis Breakdown: Supported by a negative Insider Power Score of -32.1. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Aug 14, 2024 Sell	Warrant to Purchase Common Stock D-Return	Holubiak Myron Z Vice Chairman	CEO / President	784 314 Value: $902.0K
Aug 14, 2024 Buy	Warrant to Purchase Common Stock A-Award	Holubiak Myron Z Vice Chairman	CEO / President	784 314 Value: $902.0K
Apr 03, 2024 Buy	Warrant to Purchase Common Stock A-Award	Mazur Leonard L Chief Executive Officer	CEO / President	1 165 048 Value: $1.65M
Apr 03, 2024 Sell	Warrant to Purchase Common Stock D-Return	Mazur Leonard L Chief Executive Officer	CEO / President	1 165 048 Value: $1.65M
Apr 03, 2024 Buy	Warrant to Purchase Common Stock A-Award	Holubiak Myron Z Vice Chairman	CEO / President	129 450 Value: $183.8K
Apr 03, 2024 Sell	Warrant to Purchase Common Stock D-Return	Holubiak Myron Z Vice Chairman	CEO / President	129 450 Value: $183.8K
Apr 03, 2024 Sell	Warrant to Purchase Common Stock D-Return	Holubiak Myron Z Vice Chairman	CEO / President	129 450 Value: $183.8K
Apr 03, 2024 Buy	Warrant to Purchase Common Stock A-Award	Holubiak Myron Z Vice Chairman	CEO / President	129 450 Value: $183.8K
Apr 03, 2024 Sell	Warrant to Purchase Common Stock D-Return	Mazur Leonard L Chief Executive Officer	CEO / President	1 165 048 Value: $1.65M
Apr 03, 2024 Buy	Warrant to Purchase Common Stock A-Award	Mazur Leonard L Chief Executive Officer	CEO / President	1 165 048 Value: $1.65M
Mar 14, 2024 Buy	Stock Option (Right to Purchase Common Stock) A-Award	Smith Robert Joseph Director	Director	75 000 Value: $51.8K
Mar 14, 2024 Buy	Stock Option (Right to Purchase Common Stock) A-Award	Smith Robert Joseph Director	Director	75 000 Value: $51.8K
Mar 13, 2024 Buy	Common Stock M-Exempt	Holuka Eugene Myron Director	Director	2 415 Value: $36
Mar 13, 2024 Sell	Common Stock F-InKind	Holuka Eugene Myron Director	Director	48 Value: $36
Mar 13, 2024 Buy	Stock Option (Right to Purchase Common Stock) M-Exempt	Holuka Eugene Myron Director	Director	2 415 Value: $36
Mar 13, 2024 Buy	Stock Option (Right to Purchase Common Stock) M-Exempt	Holuka Eugene Myron Director	Director	2 415 Value: $36
Mar 13, 2024 Sell	Common Stock F-InKind	Holuka Eugene Myron Director	Director	48 Value: $36
Mar 13, 2024 Buy	Common Stock M-Exempt	Holuka Eugene Myron Director	Director	2 415 Value: $36
Mar 12, 2024 Buy	Common Stock J-Other	Smith Robert Joseph	Director	0 Value: $0
Mar 12, 2024 Buy	Common Stock J-Other	Smith Robert Joseph	Director	0 Value: $0
Mar 04, 2024 Buy	Common Stock M-Exempt	Webb Carol Director	Director	12 071 Value: $181
Mar 04, 2024 Sell	Common Stock F-InKind	Webb Carol Director	Director	236 Value: $181
Mar 04, 2024 Buy	Stock Option (Right to Purchase Common Stock) M-Exempt	Webb Carol Director	Director	12 071 Value: $181
Mar 04, 2024 Buy	Stock Option (Right to Purchase Common Stock) M-Exempt	Webb Carol Director	Director	12 071 Value: $181
Mar 04, 2024 Sell	Common Stock F-InKind	Webb Carol Director	Director	236 Value: $181

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT CITIUS PHARMACEUTICALS INC

Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected c...

Read Full Profile Here